Evidence map›Paper›PMID 34218964›Full record

SynthesisAmerican journal of preventive medicine2021

Supervised Injection Facilities as Harm Reduction: A Systematic Review.

Timothy W Levengood, Grace H Yoon, Melissa J Davoust, Shannon N Ogden, Brandon D L Marshall, Sean R Cahill, Angela R Bazzi

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in American journal of preventive medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 4 pooled it
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 4 syntheses or guidelines pooled it, 210 citations in OpenAlex.

  1. Supervised consumption sites and population-level overdose mortality: a systematic review of recent evidence, 2016-2024.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Self-Injury Mortality: Global Ascertainment and Prevention.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Weather-Related Trends in Drug Use Incidents Aboard Transit Vehicles.Journal of urban health : bulletin of the New York Academy of Medicine · 2026
    Article
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Timothy W LevengoodDepartment of Health, Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts. Electronic address: tleven@bu.edu.
Grace H YoonDepartment of Health, Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts.
Melissa J DavoustDepartment of Health, Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts.
Shannon N OgdenDepartment of Health, Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts.
Brandon D L MarshallDepartment of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
Sean R CahillDepartment of Health, Law, Policy & Management, Boston University School of Public Health, Boston, Massachusetts; Director of Health Policy Research, The Fenway Institute, Boston, Massachusetts.
Angela R BazziThe Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, California; Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts.
Boston University · USBrown University · USHuman Longevity (United States) · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Project 4: Neonatal Abstinence Syndrome (NAS): Fetus to First YearsP20GM125507 · NIGMS · RHODE ISLAND HOSPITAL · PI CURT G BECKWITH · 2018 to 2026
$23.4M
Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention TrialR01DA046620 · NIDA · BROWN UNIVERSITY · PI CERDA, MAGDALENA, MARSHALL, BRANDON DAVID LEWIS · 2019 to 2023
$3.8M
Efficacy of a community-based PrEP uptake intervention for people who inject drugs in the US NortheastR01DA051849 · NIDA · BROWN UNIVERSITY · PI BAZZI, ANGELA ROBERTSON, BIELLO, KATIE BROOKS · 2020 to 2024
$3.7M
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K01 DA043412NIDA NIH HHS R01 DA046620NIDA NIH HHS R01 DA051849NIGMS NIH HHS P20 GM125507
6 · The paper itself

Abstract

contextSupervised injection facilities are harm reduction interventions that allow people who inject drugs to use previously obtained substances under the supervision of health professionals. Although currently considered illegal under U.S. federal law, several U.S. cities are considering implementing supervised injection facilities anyway as a response to the escalating overdose crisis. The objective of this review is to determine the effectiveness of supervised injection facilities, compared with that of control conditions, for harm reduction and community outcomes. EVIDENCE ACQUISITION: Studies were identified from 2 sources: a high-quality, broader review examining supervised injection facility-induced benefits and harms (from database inception to January 2014) and an updated search using the same search strategy (January 2014‒September 2019). Systematic review methods developed by the Guide to Community Preventive Services were used (screening and analysis, September 2019‒December 2020). EVIDENCE SYNTHESIS: A total of 22 studies were included in this review: 16 focused on 1 supervised injection facility in Vancouver, Canada. Quantitative synthesis was not conducted given inconsistent outcome measurement across the studies. Supervised injection facilities in the included studies (n=number of studies per outcome category) were mostly associated with significant reductions in opioid overdose morbidity and mortality (n=5), significant improvements in injection behaviors and harm reduction (n=7), significant improvements in access to addiction treatment programs (n=7), and no increase or reductions in crime and public nuisance (n=7).

conclusionsFor people who inject drugs, supervised injection facilities may reduce the risk of overdose morbidity and mortality and improve access to care while not increasing crime or public nuisance to the surrounding community.

Indexed as

Drug OverdoseSubstance Abuse, IntravenousCanadaHarm ReductionHumansNeedle-Exchange Programs

Identifiers

PMID34218964
PMCPMC8541900
OpenAlexW3177916459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.